Changeflow GovPing Pharma & Drug Safety Identification and Monitoring of Immunoglobulin...
Routine Notice Added Final

Identification and Monitoring of Immunoglobulin J Chains

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Peptides (C07K)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent application EP3681907A1 for Mayo Foundation for Medical Education and Research, covering methods for identifying and monitoring Immunoglobulin J Chains. The application (Kind A1) was published March 25, 2026, with inventors David L. Murray and David R. Barnidge, designating 40 European contracting and validating states.

What changed

The EPO published patent application EP3681907A1 titled 'Identification and Monitoring of Immunoglobulin J Chains' filed by Mayo Foundation for Medical Education and Research. The application covers methods and compositions for identifying and monitoring immunoglobulin J chains, with inventors David L. Murray and David R. Barnidge. The publication kind is A1, indicating the publication includes the search report. Designated states include all EU member states plus Switzerland, Norway, Turkey, and others (40 states total).

For companies in the biotechnology and pharmaceutical sectors, this patent publication establishes intellectual property claims that may affect freedom-to-operate for diagnostic or therapeutic products targeting J chains. Affected parties should review the patent claims for potential licensing needs once the application proceeds to grant. Patent prosecution continues through the EPO examination phase; no immediate compliance obligations arise from this publication.

Source document (simplified)

← EPO Patent Bulletin

IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J CHAINS

Publication EP3681907A1 Kind: A1 Mar 25, 2026

Applicants

Mayo Foundation for Medical Education and Research

Inventors

MURRAY, David L., BARNIDGE, David R.

IPC Classifications

G01N 33/68 20060101AFI20210531BHEP C07K 16/06 20060101ALI20210531BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Identification and Monitoring of Immunoglobulin J Chains

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3681907A1
Docket
EP3681907

Who this affects

Industry sector
3254 Pharmaceutical Manufacturing 6211 Healthcare Providers 3254.1 Biotechnology
Activity scope
Biotechnology Patents Medical Diagnostics Patents
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.